Typically, the elevation of serum IL-6 associated with CRS occurs within 3 weeks after CAR-T cell infusion, so the “double peaks of IL-6” is identified as one of the characteristics of life-threatening infections. The gene discussed is IL6; the disease is congenital rubella syndrome.